Sunitinib causes macrocytosis in patients with advanced renal cell carcinoma

Current Oncology

Volumn 17, Issue 2, 2010, Pages 30-33

  Price, J ^a   Shaarbaf, R ^b   Wood, L ^b  

^a CROSS CANCER INSTITUTE   (Canada)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Macrocytosis; Renal cell carcinoma; Sunitinib

Indexed keywords

CYANOCOBALAMIN; SUNITINIB; THYROTROPIN;

ADVANCED CANCER; ANEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; FEMALE; FOLIC ACID BLOOD LEVEL; HEMATOLOGY; HUMAN; KIDNEY CARCINOMA; MALE; MEAN CORPUSCULAR VOLUME; MEGALOCYTOSIS; MULTIPLE CYCLE TREATMENT; THYROID FUNCTION; TREATMENT DURATION; VITAMIN BLOOD LEVEL;

EID: 77950553265     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.v17i2.470     Document Type: Article

References (12)

1. Motzer RJ, Hutson TE, Tomczak P, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 2007;356:115-24.
2. Gillessen S, Graf L, Korte W, Cerny T. Macrocytosis and cobalamin deficiency in patients treated with sunitinib. N Engl J Med 2007;356:2330-1.
3. Billemont B, Izzedine H, Rixe O. Macrocytosis due to treatment with sunitinib. N Engl J Med 2007;357:1351-2.
4. Rini BI, Choueiri TK, Elson P, et al. Sunitinib-induced macro-cytosis in patients with metastatic renal cell carcinoma. Cancer 2008;113:1309-14.
5. Aslinia F, Mazza JJ, Yale SH. Megaloblastic anemia and other causes of macrocytosis. Clin Med Res 2006;4:236-41.
6. Rini BI, Tamaskar I, Shaheen P, et al. Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib. J Natl Cancer Inst 2007;99:81-3.
7. Desai J, Yassa L, Marqusee E, et al. Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors. Ann Intern Med 2006;145:660-4.
8. Karvellas CJ, Sawyer M, Hamilton M, Mackey JR. Effect of capecitabine on mean corpuscular volume in patients with metastatic breast cancer. Am J Clin Oncol 2004;27:364-8.
9. Wenzel C, Mader RM, Steger GG, et al. Capecitabine treatment results in increased mean corpuscular volume of red blood cells in patients with advanced solid malignancies. Anticancer Drugs 2003;14:119-23.
10. Sausville EA, Longo DL. Principles of cancer treatment: surgery, chemotherapy, and biologic therapy. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, eds. Harrison's Principles of Internal Medicine. 16th ed. New York: McGraw-Hill; 2005: 470-8.
11. Babior BM, Bunn HF. Megaloblastic anemias. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, eds. Harrison's Principles of Internal Medicine. 16th ed. New York: McGraw-Hill; 2005: 601-7.
12. Aliberti S, Grignani G, Allione P, et al. Erythrocyte macrocytosis is a rather common, apparently uneventful yet unexplained finding in gist imatinib (i) chronic therapy [abstract 9045]. Proc Am Soc Clin Oncol 2005;23:. [Available online at: www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=34&abstractID=31884; cited February 2, 2010]